Natural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugs
19 avr. 2024 07h35 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer...
Apoptosis Assays Market Sees Robust Growth, Driven by Advances in Biomedical Research and Drug Development
05 janv. 2024 03h58 HE
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Apoptosis Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Global Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027
06 juil. 2022 07h18 HE
|
Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product &...
Research Report on China's Lobaplatin Market, 2021-2025 Featuring Hainan Changan International Pharmaceutical
31 déc. 2021 04h58 HE
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Research Report on China's Lobaplatin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. Since its launch in China,...
Proto Oncogene Protein C-MYC Inhibitors Industry 2021 Featuring Insights for 15+ Companies and Drugs, Including RRx-001 (EpicentRx) and WP1066 (Moleculin Biotech)
23 déc. 2021 05h28 HE
|
Research and Markets
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Proto Oncogene Protein C-MYC Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...
Global Proto Oncogene Proteins C PIM 1 Inhibitors Market Landscape 2021 | Analysis of Emerging Drugs, Therapeautics, Major Players, Pipeline Activities, Trends, and Future Opportunities
22 déc. 2021 06h49 HE
|
Research and Markets
Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Proto Oncogene Proteins C PIM 1 Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report...
Global Stat Inhibitors Pipeline Landscape 2021 Featuring Over 25 Drugs and Companies, Including Bio-Path, Jiangsu Hengrui Medicine Co, Reata Pharmaceuticals, Tvardi Therapeutics, and Purple Biotech
20 déc. 2021 06h58 HE
|
Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Stat Inhibitors - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive...
Global Targeted Therapeutics Market Research Report 2021: Market will Surpass $100+ Billion in 2021 - Forecast to 2026
15 déc. 2021 09h03 HE
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Targeted Therapeutics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for targeted...
Nitric Oxide Markets, Therapeutics, and Competitive Landscape Report 2021 with Profiles of 36 Companies
18 nov. 2021 07h33 HE
|
Research and Markets
Dublin, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Provectus Biopharmaceuticals Announces Publication of In Vitro Data from Research on Oral Delivery of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
09 juin 2021 07h00 HE
|
Provectus Biopharmaceuticals Inc.
— PV-10 treatment induced autophagic cell death in all breast, colorectal, head and neck, and testicular cancer cell lines tested — Represents prerequisite in vitro data for clinical testing...